AAAAAA

   
Results: 1-9 |
Results: 9
Scientific blueprint for tuberculosis drug development - Global alliance for TB drug development
Authors: Barry, C Cole, S Fourie, B Geiter, L Gosey, L Grosset, J Kanyok, T Laughon, B Mitchison, D Nunn, P O'Brien, R Robinson, T Annick-Mouries, M Cynamon, M Duncan, K Goldberger, M Gutteridege, W Kioy, D Pablos-Mendez, A Orme, I Rieder, H Roscigno, G Vernon, A
Citation: C. Barry et al., Scientific blueprint for tuberculosis drug development - Global alliance for TB drug development, TUBERCULOSI, 81, 2001, pp. 1-52
Interphase fluorescence in situ hybridization assay for the detection of 3q21 rearrangements in myeloid malignancies
Authors: Wieser, R Schreiner, U Pirc-Danoewinata, H Aytekin, M Schmidt, HH Rieder, H Fonatsch, C
Citation: R. Wieser et al., Interphase fluorescence in situ hybridization assay for the detection of 3q21 rearrangements in myeloid malignancies, GENE CHROM, 32(4), 2001, pp. 373-380
MDR-1 expression and deletions of chromosomes 7 and 5(Q) separately indicate adverse prognosis in AML
Authors: Baldus, C Fietz, T Rieder, H Schwartz, S Thiel, E Knauf, W
Citation: C. Baldus et al., MDR-1 expression and deletions of chromosomes 7 and 5(Q) separately indicate adverse prognosis in AML, LEUK LYMPH, 40(5-6), 2001, pp. 613-623
Masked inv(3)(q21q26) in a patient with minimally differentiated acute myeloid leukemia
Authors: Wieser, R Schreiner, U Wollenberg, B Neubauer, A Fonatsch, C Rieder, H
Citation: R. Wieser et al., Masked inv(3)(q21q26) in a patient with minimally differentiated acute myeloid leukemia, HAEMATOLOG, 86(2), 2001, pp. 214-215
Marked differences in unilateral isolated retinoblastomas from young and older children studied by comparative genomic hybridization
Authors: Herzog, S Lohmann, DR Buiting, K Schuler, A Horsthemke, B Rehder, H Rieder, H
Citation: S. Herzog et al., Marked differences in unilateral isolated retinoblastomas from young and older children studied by comparative genomic hybridization, HUM GENET, 108(2), 2001, pp. 98-104
Partial deletions of the long and short arm of chromosome 3 point to two tumor suppressor genes in uveal melanoma
Authors: Tschentscher, F Prescher, G Horsman, DE White, VA Rieder, H Anastassiou, G Schilling, H Bornfeld, N Bartz-Schmidt, KU Horsthemke, B Lohmann, DR Zeschnigk, M
Citation: F. Tschentscher et al., Partial deletions of the long and short arm of chromosome 3 point to two tumor suppressor genes in uveal melanoma, CANCER RES, 61(8), 2001, pp. 3439-3442
Treatment of adult ALL according to protocols of the German Multicenter Study Group for Adult ALL (GMALL)
Authors: Gokbuget, N Hoelzer, D Arnold, R Bohme, A Bartram, CR Freund, M Ganser, A Kneba, M Langer, W Lipp, T Ludwig, WD Maschmeyer, G Rieder, H Thiel, E Weiss, A Messerer, D
Citation: N. Gokbuget et al., Treatment of adult ALL according to protocols of the German Multicenter Study Group for Adult ALL (GMALL), HEMAT ONCOL, 14(6), 2000, pp. 1307
Culturing human umbilical cord blood: a comparison of mononuclear vs CD34(+) selected cells
Authors: Fietz, T Berdel, WE Rieder, H Reufi, B Hopp, H Thiel, E Knauf, WU
Citation: T. Fietz et al., Culturing human umbilical cord blood: a comparison of mononuclear vs CD34(+) selected cells, BONE MAR TR, 23(11), 1999, pp. 1109-1115
Germ-line mutations in the gene for multiple endocrine neoplasia type 1 (MEN 1): basis for predictive genetic screening and clinical management of MEN 1 families
Authors: Bartsch, D Kopp, I Bergenfelz, A Rieder, H Deiss, Y Munch, K Rothmund, M Simon, B
Citation: D. Bartsch et al., Germ-line mutations in the gene for multiple endocrine neoplasia type 1 (MEN 1): basis for predictive genetic screening and clinical management of MEN 1 families, DEUT MED WO, 123(51-52), 1998, pp. 1535-1540
Risultati: 1-9 |